*After antioxidant activity, oxidized Vitamin E is reduced by Vitamin C, and oxidized Vitamin C is reduced by glutathione
Notably, the MC4R agonist setmelanotide (IMCIVREE) was recently approved by the US FDA to manage BBS-associated weight gain and is under evaluation for additional therapeutic effects in BBS patients (45, 46)

These tests may include 25 : Complete blood count (CBC) to screen for anemia and conditions affecting red or white blood cells or platelets Comprehensive metabolic panel to check kidney function and general health status Erythrocyte sedimentation rate (ESR) and/or C-reactive protein (CRP) to screen for inflammatory disorders Thyroid stimulating hormone (TSH) to rule out thyroid disease 25-hydroxy vitamin D to identify cases of deficiency Ferritin to assess iron status, especially in those with fatigue, cognitive dysfunction, restless leg syndrome, or a high risk of deficiency Vitamin B12 to test for deficiency, especially in cases involving cognitive dysfunction Various additional blood tests may be ordered when indicated to rule out other suspected diagnoses, such as autoimmune diseases, muscle diseases, neurologic disorders, and infections

Although there is a lack of direct studies on semaglutide, the observed actions align with those of other GLP-1R agonists, indicating a potential impact on cancer
L- , -